X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs VENUS REMEDIES - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA VENUS REMEDIES FULFORD INDIA/
VENUS REMEDIES
 
P/E (TTM) x 398.8 -819.1 - View Chart
P/BV x 6.2 0.2 2,594.4% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   VENUS REMEDIES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
VENUS REMEDIES
Mar-16
FULFORD INDIA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs942218 432.1%   
Low Rs45082 548.1%   
Sales per share (Unadj.) Rs691.4365.6 189.1%  
Earnings per share (Unadj.) Rs11.51.5 771.3%  
Cash flow per share (Unadj.) Rs15.437.9 40.5%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0382.5 99.3%  
Shares outstanding (eoy) m3.9011.44 34.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.4 245.3%   
Avg P/E ratio x60.7101.0 60.1%  
P/CF ratio (eoy) x45.34.0 1,145.2%  
Price / Book Value ratio x1.80.4 466.9%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7141,717 158.1%   
No. of employees `0000.41.0 43.5%   
Total wages/salary Rs m505324 155.7%   
Avg. sales/employee Rs Th6,073.04,100.7 148.1%   
Avg. wages/employee Rs Th1,137.4318.0 357.6%   
Avg. net profit/employee Rs Th100.716.7 604.1%   
INCOME DATA
Net Sales Rs m2,6964,183 64.5%  
Other income Rs m12520 623.9%   
Total revenues Rs m2,8224,203 67.1%   
Gross profit Rs m-46812 -5.7%  
Depreciation Rs m15417 3.6%   
Interest Rs m10380 2.5%   
Profit before tax Rs m5435 154.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1018 53.0%   
Profit after tax Rs m4517 262.9%  
Gross profit margin %-1.719.4 -8.9%  
Effective tax rate %17.751.6 34.3%   
Net profit margin %1.70.4 407.9%  
BALANCE SHEET DATA
Current assets Rs m1,7382,771 62.7%   
Current liabilities Rs m5451,931 28.2%   
Net working cap to sales %44.320.1 220.6%  
Current ratio x3.21.4 222.5%  
Inventory Days Days48125 38.8%  
Debtors Days Days454 8.0%  
Net fixed assets Rs m125,328 0.2%   
Share capital Rs m39114 34.1%   
"Free" reserves Rs m1,4434,177 34.5%   
Net worth Rs m1,4824,376 33.9%   
Long term debt Rs m01,911 0.0%   
Total assets Rs m2,0778,428 24.6%  
Interest coverage x6.71.1 614.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.5 261.6%   
Return on assets %2.64.7 55.4%  
Return on equity %3.00.4 776.4%  
Return on capital %4.36.6 65.2%  
Exports to sales %00-   
Imports to sales %24.520.5 119.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659858 76.8%   
Fx inflow Rs m170-   
Fx outflow Rs m673858 78.4%   
Net fx Rs m-656-858 76.4%   
CASH FLOW
From Operations Rs m90469 19.2%  
From Investments Rs m10529 358.2%  
From Financial Activity Rs m-14-464 3.0%  
Net Cashflow Rs m18135 523.2%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 0.2 2,111.1%  
FIIs % 0.1 0.6 17.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 66.4 31.9%  
Shareholders   4,783 20,121 23.8%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare FULFORD INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS